Vaxart, Inc. (VXRT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 40M 80M 120M Q3 '16: 100K Q4 '16: 3.8M Q1 '17: 2.3M Q2 '17: 1.9M Q3 '17: 915K Q4 '17: 2.7M Q1 '18: 1.5M Q2 '18: 608K Q3 '18: 281K Q4 '18: 1.8M Q1 '19: 5.4M Q2 '19: 85K Q3 '19: 454K Q4 '19: 3.9M Q1 '20: 2.9M Q2 '20: 523K Q3 '20: 265K Q4 '20: 356K Q1 '21: 506K Q2 '21: 112K Q3 '21: 200K Q4 '21: 74K Q1 '22: 85K Q2 '22: 0 Q3 '22: 0 Q4 '22: 22K Q1 '23: 675K Q2 '23: 1.4M Q3 '23: 2.1M Q4 '23: 3.2M Q1 '24: 2.2M Q2 '24: 6.4M Q3 '24: 4.9M Q4 '24: 15.2M Q1 '25: 20.9M Q2 '25: 39.7M Q3 '25: 72.4M Q4 '25: 104.2M Q1 '26: 39.2M Q2 '26: 27.2M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

-21M -14M -7M 0 7M 14M 21M Q3 '12: 0 Q4 '12: 3.3M Q1 '13: 8.4M Q2 '13: 1.6M Q3 '13: -4M Q4 '13: -100K Q1 '14: 3.2M Q2 '14: -10.5M Q3 '14: -7M Q4 '14: 6.4M Q1 '15: 1.1M Q2 '15: -20M Q3 '15: -6.7M Q4 '15: -6.5M Q1 '16: -5.2M Q2 '16: -6.8M Q4 '12 Q2 '13 Q4 '13 Q2 '14 Q4 '14 Q2 '15 Q4 '15 Q2 '16

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-40M -20M 0 20M 40M 60M Q3 '16: -9.6M Q4 '16: -8.6M Q1 '17: -2.2M Q2 '17: -3.1M Q3 '17: -2M Q4 '17: -2.9M Q1 '18: -3.9M Q2 '18: -7.8M Q3 '18: -5.9M Q4 '18: -4.2M Q1 '19: -448K Q2 '19: -5M Q3 '19: -4.7M Q4 '19: -5.6M Q1 '20: -694K Q2 '20: -8.5M Q3 '20: -7.6M Q4 '20: -13.4M Q1 '21: -15.5M Q2 '21: -15.8M Q3 '21: -17.3M Q4 '21: -24.2M Q1 '22: -24.8M Q2 '22: -29.2M Q3 '22: -29.4M Q4 '22: -31.1M Q1 '23: -25.6M Q2 '23: -23.1M Q3 '23: -17.8M Q4 '23: -16.9M Q1 '24: -24.1M Q2 '24: -16.3M Q3 '24: -14.5M Q4 '24: -11.5M Q1 '25: -14.9M Q2 '25: -14.6M Q3 '25: -7.8M Q4 '25: 55.4M Q1 '26: 5.2M Q2 '26: -13.2M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-40M -20M 0 20M 40M 60M Q3 '16: -10M Q4 '16: -9.1M Q1 '17: -2.8M Q2 '17: -3.5M Q3 '17: -2.2M Q4 '17: -3.4M Q1 '18: 2.3M Q2 '18: -8.9M Q3 '18: -6.5M Q4 '18: -4.9M Q1 '19: -1.3M Q2 '19: -5.6M Q3 '19: -5.3M Q4 '19: -6.4M Q1 '20: -1.3M Q2 '20: -9M Q3 '20: -8.1M Q4 '20: -13.9M Q1 '21: -16M Q2 '21: -16.1M Q3 '21: -17.6M Q4 '21: -20.8M Q1 '22: -25.1M Q2 '22: -29.4M Q3 '22: -29.3M Q4 '22: -23.9M Q1 '23: -25.1M Q2 '23: -22.6M Q3 '23: -17.4M Q4 '23: -17.4M Q1 '24: -24.4M Q2 '24: -16.5M Q3 '24: -14.1M Q4 '24: -12M Q1 '25: -15.6M Q2 '25: -15M Q3 '25: -8.1M Q4 '25: 55M Q1 '26: 5.2M Q2 '26: -13.5M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 9M 18M 27M Q3 '12: 1.5M Q4 '12: 7.1M Q1 '13: 4.1M Q2 '13: 7.7M Q3 '13: 16.3M Q4 '13: 18.6M Q1 '14: 26.3M Q2 '14: 19M Q3 '14: 7.7M Q4 '14: 7.5M Q1 '15: 4.8M Q2 '15: 24.1M Q3 '15: 8.4M Q4 '15: 8.2M Q1 '16: 10.5M Q2 '16: 7.4M Q4 '12 Q2 '13 Q4 '13 Q2 '14 Q4 '14 Q2 '15 Q4 '15 Q2 '16

Operating Cash Flow Quarterly

-30M -15M 0 15M 30M 45M Q3 '16: -10.7M Q4 '16: -9M Q1 '17: -4.3M Q2 '17: -1.7M Q3 '17: -4.5M Q4 '17: -4.7M Q1 '18: -10.6M Q2 '18: 7.1M Q3 '18: -5.4M Q4 '18: -5.7M Q1 '19: -4.7M Q2 '19: -317K Q3 '19: -4.3M Q4 '19: -3.8M Q1 '20: -3.2M Q2 '20: -521K Q3 '20: -9.3M Q4 '20: -10.8M Q1 '21: -16.6M Q2 '21: -13.2M Q3 '21: -14.3M Q4 '21: -15.8M Q1 '22: -25.1M Q2 '22: -25.9M Q3 '22: -14.6M Q4 '22: -29.2M Q1 '23: -24.5M Q2 '23: -17.5M Q3 '23: -15M Q4 '23: -13.5M Q1 '24: -21.2M Q2 '24: -12M Q3 '24: -4.2M Q4 '24: -7.3M Q1 '25: -9.6M Q2 '25: -15.9M Q3 '25: 2.6M Q4 '25: 30.7M Q1 '26: -2.1M Q2 '26: 2.8M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '13: -6.3M Q4 '13: -8.4M Q1 '14: 600K Q1 '17: -4.4M Q2 '17: -1.8M Q3 '17: -4.5M Q4 '17: -4.7M Q1 '18: -10.7M Q2 '18: 6.9M Q3 '18: -5.5M Q4 '18: -5.9M Q1 '19: -5.2M Q2 '19: -476K Q3 '19: -4.5M Q4 '19: -3.8M Q1 '20: -3.2M Q2 '20: -530K Q3 '20: -9.6M Q4 '20: -11.7M Q1 '21: -17.2M Q2 '21: -15.4M Q3 '21: -15.6M Q4 '21: -16.8M Q1 '22: -26.5M Q2 '22: -28.2M Q3 '22: -16.6M Q4 '22: -33.1M Q1 '23: -25.7M Q2 '23: -17.9M Q3 '23: -15.3M Q1 '24: -21.3M Q2 '24: -12.4M Q3 '24: -4.2M Q4 '24: -7.4M Q1 '25: -9.7M Q2 '25: -16M Q3 '25: 2.5M Q4 '25: 30.7M Q1 '26: -2.5M Q2 '26: 2.7M Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 90M 180M 270M Q3 '11: 42.4M Q4 '11: 22.7M Q1 '12: 22.7M Q2 '12: 42.7K Q3 '12: 22.8M Q4 '12: 28.4M Q1 '13: 28.2M Q3 '13: 28.3M Q4 '13: 28.3M Q1 '14: 34.3M Q3 '14: 35M Q4 '14: 35.1M Q1 '15: 35.1M Q3 '15: 38.6M Q4 '15: 38.6M Q1 '16: 38.6M Q3 '16: 38.6M Q4 '16: 38.6M Q1 '17: 135.7K Q3 '17: 38.6M Q4 '17: 38.6M Q1 '18: 5.3M Q1 '19: 7.3M Q1 '21: 115.4M Q2 '21: 120.9M Q3 '21: 124M Q1 '22: 125.8M Q2 '22: 126.4M Q3 '22: 126.9M Q1 '23: 135.2M Q2 '23: 139.6M Q3 '23: 152M Q1 '24: 168.8M Q2 '24: 184.7M Q3 '24: 227.5M Q1 '25: 227.9M Q2 '25: 228.4M Q3 '25: 228.9M Q1 '26: 242.2M Q2 '26: 242.2M Q3 '12 Q1 '14 Q4 '15 Q3 '17 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-30.00 -20.00 -10.00 0.00 10.00 20.00 30.00 Q3 '16: -0.75 Q4 '16: -0.82 Q1 '17: -26.52 Q2 '17: -26.49 Q3 '17: -26.37 Q4 '17: -26.22 Q1 '18: 0.11 Q2 '18: -0.98 Q3 '18: -1.76 Q4 '18: -2.36 Q1 '19: -3.03 Q2 '19: -2.18 Q3 '19: -1.58 Q4 '19: -1.02 Q1 '20: -0.86 Q2 '20: -0.59 Q3 '20: -0.35 Q4 '20: -0.35 Q1 '21: -0.47 Q2 '21: -0.48 Q3 '21: -0.54 Q4 '21: -0.58 Q1 '22: -0.64 Q2 '22: -0.74 Q3 '22: -0.83 Q4 '22: -0.84 Q1 '23: -0.83 Q2 '23: -0.76 Q3 '23: -0.64 Q4 '23: -0.58 Q1 '24: -0.53 Q2 '24: -0.46 Q3 '24: -0.41 Q4 '24: -0.34 Q1 '25: -0.27 Q2 '25: -0.25 Q3 '25: -0.23 Q4 '25: 0.07 Q1 '26: 0.16 Q2 '26: 0.17 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.